Pfizer-BioNTech Evaluating Third COVID-19 Vaccine Dose for Variants
The new trial comes at a time when the FDA has provided guidance on navigating immunogenicity trials for vaccines designed against more transmissible SARS-CoV-2 strains.
The new trial comes at a time when the FDA has provided guidance on navigating immunogenicity trials for vaccines designed against more transmissible SARS-CoV-2 strains.
Shifting to Outpatient Care for Acute Bacterial Skin and Skin Structure Infections Philip A. Giordano, MD, FACEP Program Director, PGY2 Emergency Medicine Pharmacy Residency Philip…
A survey of this population showed that over a 2 and ½ year period, there was a decrease in post-acute sequelae of SARS-CoV-2 infection (PASC).…
Updated recommendations simplify vaccine eligibility, favoring PCV21 while addressing cost-effectiveness and racial health disparities.
Selective serotonergic reuptake inhibitors (SSRIs) and beta-adrenergic blockers among agents with potential to mitigate chronic wound infections.
CEO Larry D Sutton, MD, PhD, elaborates on the company’s strategy and the science behind SIDIPREV to prevent C difficile infections in hospitalized patients.
In a retrospective cohort study, a health system found this form of prophylaxis led to substantial reductions in 2 of 3 sexually transmitted infections (STIs)…
Nationwide norovirus cases have recently increased, followed by an FDA warning for consumers to avoid oysters contaminated in a recent outbreak.
The Centers for Disease Control and Prevention (CDC) has reported a case in Louisiana where the patient is hospitalized due to the virus, and had…
A novel approach may identify resistance earlier and get patients on a proper course of antifungals sooner.
A case series of 13 patients suggests that extended courses of Paxlovid could benefit some Long COVID patients, but the results are inconsistent.